APPENDICES - NIHR Health Technology Assessment Programme

More documents

Recommendations

Info

146 Appendix 6 aminolevulinic acid (MAL-PDT).] Przegl Dermatol 2007;94:599–605. 154. Pons P, Pittau R, Boetto N, Garzon R, Aoki A. [Photodynamic therapy of neoplastic skin lesions: a two year experience.] Rev Arg Dermatol 2001;82:208–15. 155. Privalov VA, Lappa AV, Seliverstov OV, Faizrakhmanov AB, Yarovoy NN, Kochneva EV, et al. Clinical trials of a new chlorin photosensitizer for photodynamic therapy of malignant tumors. Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XI. SPIE Proceedings 2002;4612:178–89. 156. Pye A, Campbell S, Curnow A. Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. J Cancer Res Clin Oncol 2008;134:841–9. 157. Recio ED, Zambrano B, Alonso ML, de Eusebio E, Martin M, Cuevas J, et al. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature. Int J Dermatol 2008;47:410–13. 158. Reshetnikov AV. Summary on Radachlorin/Radachlorin Research [unpublished.] In. Moscow: RADA-PHARMA Co. Ltd; 2005. 159. Rossi R, Puccioni M, Mavilia L, Campolmi P, Mori M, Cappuccini A, et al. Squamous cell carcinoma of the eyelid treated with photodynamic therapy. J Chemother 2004;16:306–9. 160. Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 2000;43:499–502. 161. Sacchini V, Melloni E, Marchesini R, Luini A, Bandieramonte G, Spinelli P, et al. Preliminary clinical studies with PDT by topical TPPS administration in neoplastic skin lesions. Lasers Surg Med 1987;7:6–11. 162. Sacchini V, Melloni E, Santoro O, Marchesini R, Cascinelli N, Bandieramonte G. Photodynamic therapy by TPPS topical application and dye-laser in basal-cell carcinoma. SPIE Proceedings Series 1989;1066:173–6. 163. Salgado A, Fujimura M, Secco L. Case report: Basal cell carcinoma treated with photodynamic therapy and yellow light. J Am Acad Dermatol 2007;56:A206. 164. Salvini C, Massi D, Cappugi P. Recurrent basal cell carcinoma of the nose successfully treated by photodynamic therapy. J Eur Acad Dermatol Venereol 2009;23:73–5. 165. Santoro O, Bandieramonte G, Melloni E, Marchesini R, Zunino F, Lepera P, et al. Photodynamic therapy by topical mesotetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas. Cancer Res 1990;50:4501–3. 166. Schleier P, Berndt A, Kolossa S, Wood M. Comparison between mALA- and ALA-PDT in the treatment of basal cell carcinomas. Oral Oncol 2005;1(Suppl.):67–8. 167. Schleier P, Hyckel P, Berndt A, Bode H-P, Albrecht V, Hindermann W, et al. Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients. J Cancer Res Clin Oncol 2004;130:279–84. 168. Schweitzer VG, Visscher D. Photodynamic therapy for treatment of AIDS-related oral Kaposi’s sarcoma. Otolaryngol Head Neck Surg 1990;102:639– 49. 169. Sieron A, Kawczyk-Krupka A, Wojciech Cebula MA, Szygula M, Zieleznik W, Gruk M, et al. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of malignant skin tumors. Photodiag Photodyn Ther 2004;1:311–17. 170. Smucler R. Surgical excision versus ALA-PDT- PDL versus laser coagulation with diode laser in treatment of basal cell carcinoma (2 years study). Lasers Surg Med 2005;36:S17. 171. Smucler R, Vlk M. Combination of PDT and Er:YAG laser in treatment of nodular basal cell carcinoma. Lasers Surg Med 2007;39:S19. 172. Smucler R, Vlk M. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. Lasers Surg Med 2008;40:153–8. 173. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001;145:467–71. 174. Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Dermatol Venereol 1999;79:204–6.
DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37 175. Soler AM, Warloe T, Tausjo J, Giercksky KE. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid. Acta Oncol 2000;39:605–9. 176. Souza CS, Neves ABS, Felicio LAB, Ferreira J, Kurachi C, Bagnato VS. Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers. [Erratum published in Dermatol Surg 2007;33:523.] Dermatol Surg 2007;33:194–8. 177. Stables GI, Stringer MR, Hudson EJ, Ash DV. Topical 5-aminolaevulinic acid photodynamic therapy for Bowen’s disease and basal cell carcinoma. Br J Dermatol 1994;131:23. 178. Star WM, van’t Veen AJ, Robinson DJ, Munte K, de Haas ERM, Sterenborg HJCM. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up. Acta Dermatol Venereol 2006;86:412–17. 179. Stolz W, Landthaler M, Braun-Falco O. [Photodynamic therapy of cutaneous T-cell lymphoma in special locations: two case reports.] Hautarzt 1999;50:109–14. 180. Stranadko E, Purtskhvanidze V, Radaev A. Photodynamic therapy for skin cancer with minimized light doses and minimized doses of chlorin derivatives photosensitizers. Photodynamic Therapy and Photodiagnosis in Clinical Practice, Brixen/ Bressanone, 7–11 October 2008. Poster session – CD08. 181. Stranadko E, Skobelkin O. Experience of PDT of cancer with two Russian-produced photosensitizers. SPIE Proceedings Series 1995;2392:93–105. 182. Stranadko EF, Purtskhvanidze VA, Radaev AA. Photodynamic therapy for skin cancer with chlorin derivatives under the outpatient conditions. Laser Helsinki 2008, 13th International Congress of EMLA (European Medical Laser Association) in conjunction with EMLA Finland and MAL (Medical Acupuncture and Laser) in cooperation with ASLMS (American Society for Laser Medicine and Surgery), Helsinki, 2008. 183. Stranadko EF, Skobelkin OK, Litvin GD, Astrakhankina TA. Photodynamic therapy of human malignant tumours: a comparative study between photohem and tetrasulfonated aluminium phthalocyanine. SPIE Proceedings Series 1996;2625:440–8. 184. Stranadko EF, Skobelkin OK, Makeev YM, Markichev NA, Riabov MV, Armitchev AV, et al. Laser treatment of skin cancer: dissection, © 2010 Queen’s Printer and Controller of HMSO. All rights reserved. photodestruction, photodynamic therapy. SPIE Proceedings Series 1996;2887:63–5. 185. Stranadko EF, Skobelkin OK, Vorozhtsov GN, Beshleul SE, Markitchev NA, Riabov MV. Photodynamic therapy of cancer, five-year clinical experience. SPIE Proceedings Series 1997;3191:253– 62. 186. Stranadko EP, Ponomarev GV, Mechkov VM, Riabov MV, Ivanov AV, Reshetnikov AV, et al. The first experience of photodithazine clinical application for photodynamic therapy of malignant tumors. SPIE Proceedings Series 2000;3909:138–44. 187. Surrenti T, De Angelis L, Di Cesare A, Fargnoli MC, Peris K. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Eur J Dermatol 2007;17:412–15. 188. Surrenti T, De Angelis L, Fargnoli MC, Peris K. Efficacy, tolerability, and cosmetic outcome of MAL- PDT in the treatment of basal cell carcinoma. J Am Acad Dermatol 2006;54:A187. 189. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994;130:743–51. 190. Szeimies RM, Landthaler M. [Topical photodynamic therapy in treatment of superficial skin tumors.] Hautarzt 1995;46:315–18. 191. Taber SW, Fingar VH, Coots CT, Wieman TJ. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Clin Cancer Res 1998;4:2741–6. 192. Tardivo JP, Del Giglio A, Paschoal LH, Baptista MS. New photodynamic therapy protocol to treat AIDS-related Kaposi’s sarcoma. Photomed Laser Surg 2006;24:528–31. 193. Thiele B, Grotmann P, Huttmann G, Diddens H, Horauf H. [Topical photodynamic therapy of basal cell carcinomas (BCCS): clinical, histological and experiment results (first report).] Z Hautkrankheiten 1994;69:161–4. 194. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000;142:338–9. 195. Thissen MRTM, Kuijpers DIM, De Groot AC. [Photodynamic therapy of superficial basal cell 147
Page 1 and 2: Appendices July 2010 10.3310/hta143
Page 3 and 4: DOI: 10.3310/hta14370 Health Techno
Page 9: DOI: 10.3310/hta14370 Health Techno
Page 12 and 13: 140 Appendix 6 18. Biel MA. Photody
Page 14 and 15: 142 Appendix 6 63. Gonzalez-Perez R
Page 16 and 17: 144 Appendix 6 treated with photody
Page 20 and 21: 148 Appendix 6 carcinomas: 5 years
Page 38 and 39: 166 Appendix 9 photodynamic therapy
Page 40 and 41: 168 Appendix 9 of early-stage lung
Page 42 and 43: 170 Appendix 9 107. Okunaka T, Kato
Page 44 and 45: 172 Appendix 9 152. Kato H, Konaka
Page 54 and 55: 182 Appendix 12 as salvage treatmen
Page 56 and 57: 184 Appendix 12 63. Lorenz KJ, Maie
Page 58 and 59: 186 Appendix 12 107. Biel MA. Photo
Page 60 and 61: 188 Appendix 13 Study details Popul
Page 68 and 69:
196 Appendix 13 Study details Popul
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Appendix 13 214 Study details Popul
Page 89 and 90:
DOI: 10.3310/hta14370 Health Techno
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Study details Population details Tr
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153:
Page 156 and 157:
Page 158 and 159:
Appendix 21 286 Study details Popul
Page 162:
Feedback The HTA programme and the
show all

APPENDICES - NIHR Health Technology Assessment Programme

Create successful ePaper yourself

Delete template?

Save as template?